{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:22:26Z","timestamp":1791397346861,"version":"4.3.3"},"reference-count":52,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Sanofi Pasteur MSD"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.vaccine.2011.05.018","type":"journal-article","created":{"date-parts":[[2011,5,26]],"date-time":"2011-05-26T23:10:11Z","timestamp":1306451411000},"page":"5245-5249","source":"Crossref","is-referenced-by-count":36,"title":["Economic burden of HPV-related cancers in France"],"prefix":"10.1016","volume":"29","author":[{"given":"I.","family":"Borget","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Abramowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mathevet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.05.018_bib0005","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002","volume":"118","author":"Parkin","year":"2006","journal-title":"Int J Cancer"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2011.05.018_bib0010","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.vaccine.2006.05.111","article-title":"Chapter 2: the burden of HPV-related cancers","volume":"24","author":"Parkin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0015","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/ijc.24339","article-title":"Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?","volume":"125","author":"N\u00e4sman","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0020","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2007.14.1713","article-title":"Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States","volume":"26","author":"Chaturvedi","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cncr.20364","article-title":"Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973\u20132000","volume":"101","author":"Johnson","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0035","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.ejca.2009.07.019","article-title":"HPV infection in Europe","volume":"45","author":"De Vuyst","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0040","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0045","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejca.2009.12.014","article-title":"Estimates of cancer incidence and mortality in Europe in 2008","volume":"46","author":"Ferlay","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0050","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/ijc.24116","article-title":"Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis","volume":"124","author":"De Vuyst","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0055","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jcp.2008.063149","article-title":"Human papillomavirus prevalence and type distribution in penile carcinoma","volume":"62","author":"Miralles-Guri","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0060","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1055-9965.EPI-04-0551","article-title":"Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review","volume":"14","author":"Kreimer","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2011.05.018_bib0065","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s11864-009-0113-5","article-title":"Human papillomavirus and oropharyngeal cancer: what you need to know in 2009","volume":"10","author":"Gillespie","year":"2009","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0070","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1470-2045(10)70017-6","article-title":"HPV-associated head and neck cancer: a virus-related cancer epidemic","volume":"11","author":"Marur","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0075","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jnci\/djn025","article-title":"Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers","volume":"100","author":"Gillison","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0080","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1200\/JCO.2004.00.3335","article-title":"Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis","volume":"24","author":"Weinberger","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0085","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ejca.2010.01.026","article-title":"Expression profiles of viral responsive genes in oral and oropharyngeal cancers","volume":"46","author":"Laborde","year":"2010","journal-title":"Eur J Cancer"},{"issue":"Suppl. 10","key":"10.1016\/j.vaccine.2011.05.018_bib0090","doi-asserted-by":"crossref","first-page":"K17","DOI":"10.1016\/j.vaccine.2008.06.021","article-title":"Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions","volume":"26","author":"Giuliano","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0095","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1758-3284-1-36","article-title":"HPV & head and neck cancer: a descriptive update","volume":"1","author":"Goon","year":"2009","journal-title":"Head Neck Oncol"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.respe.2010.06.165","article-title":"Economic burden of anal cancer management in France","volume":"58","author":"Abramowitz","year":"2010","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0105","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.ygyno.2010.01.026","article-title":"Epidemiology and pathology of HPV disease in males","volume":"117","author":"Giuliano","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0110","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/sj.bjc.6604871","article-title":"An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England","volume":"100","author":"Robinson","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jadohealth.2007.08.022","article-title":"Awareness, knowledge, and beliefs about human papillomavirus in a racially diverse sample of young adults","volume":"42","author":"Gerend","year":"2008","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0120","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/CEJ.0b013e3283240607","article-title":"Awareness of human papillomavirus in 23 000 Danish men from the general male population","volume":"18","author":"Nielsen","year":"2009","journal-title":"Eur J Cancer Prev"},{"issue":"4 Suppl.","key":"10.1016\/j.vaccine.2011.05.018_bib0125","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jadohealth.2010.01.016","article-title":"Beyond cervical cancer: burden of other HPV-related cancers among men and women","volume":"46","author":"Chaturvedi","year":"2010","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0130","first-page":"p606","article-title":"Cancer incidence in five continents","volume":"vol. VIII","author":"Parkin","year":"2002"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0135","series-title":"Cancer incidence in five continents","volume":"Vol. IX","year":"2007"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0140","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.respe.2008.03.117","article-title":"Cancer incidence and mortality in France over the period 1980\u20132005","volume":"56","author":"Belot","year":"2008","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0145","unstructured":"Evolution de l\u2019incidence et de la mortalit\u00e9 par cancer en France de 1980 \u00e0 2005. Estimations \u00e0 partir des donn\u00e9es des registres du r\u00e9seau FRANCIM et du Cepi. January 2008."},{"key":"10.1016\/j.vaccine.2011.05.018_bib0150","first-page":"219","article-title":"Invasive cervical cancer treatment costs in France","volume":"94","author":"Arveux","year":"2007","journal-title":"Bull Cancer"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0155","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/030089160909500203","article-title":"Incidence of invasive cervical cancer and direct costs associated with its management in Italy","volume":"95","author":"Ricciardi","year":"2009","journal-title":"Tumori"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0160","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3111\/13696990801961611","article-title":"Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium","volume":"11","author":"Annemans","year":"2008","journal-title":"J Med Econ"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0165","first-page":"31","article-title":"Costs of management of vulvar and vaginal cancers in France","volume":"28","author":"R\u00e9my","year":"2010","journal-title":"J d\u2019\u00c9con M\u00e9d"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0170","series-title":"Presented at the 17th Congress of the European Academy of Dermatology and Venereology","article-title":"Hospitalization and management costs of patients with penile cancer in France","author":"R\u00e9my","year":"2008"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0175","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1758-3284-2-22","article-title":"Head and neck cancers in France: an analysis of the hospital medical information system (PMSI) database","volume":"2","author":"Lacau St Guily\u00a0F J.","year":"2010","journal-title":"Head Neck Oncol"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0180","first-page":"273","article-title":"Frequency and cost of thirty long-term disorders in the Midi-Pyrenees region in 2003 [In French]","volume":"36","author":"Weill","year":"2005","journal-title":"Revue M\u00e9dicale de l\u2019Assurance Maladie"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0185","series-title":"Economic analysis cost of cancer in France: impact on quality of life, prevention, detection, care, research [In French]","author":"French National Institute of Cancer (INCA)","year":"2007"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0190","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/01.MLG.0000181507.69620.14","article-title":"Quality of life and head and neck cancer: a 5 year prospective study","volume":"115","author":"Abendstein","year":"2005","journal-title":"Laryngoscope"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0195","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0360-3016(03)01454-8","article-title":"Swallowing dysfunction\u2013preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review","volume":"57","author":"Mittal","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0200","doi-asserted-by":"crossref","first-page":"c1439","DOI":"10.1136\/bmj.c1439","article-title":"Oropharyngeal carcinoma related to human papillomavirus","volume":"340","author":"Mehanna","year":"2010","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0205","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/jcp.2003.008656","article-title":"HPV infections and tonsillar carcinoma","volume":"57","author":"Syrj\u00e4nen","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0210","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/BF01303162","article-title":"U.S. householder survey of functional gastrointestinal disorders, prevalence, sociodemography, and health impact","volume":"38","author":"Drossman","year":"1993","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0215","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/bjs.4967","article-title":"Anal intraepithelial neoplasia","volume":"92","author":"Abbasakoor","year":"2005","journal-title":"Br J Surg"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0220","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1155\/2007\/159137","article-title":"HPV infection in men","volume":"23","author":"Palefsky","year":"2007","journal-title":"Dis Markers"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0225","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/QAD.0b013e3281c61201","article-title":"Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factors","volume":"21","author":"Abramowitz","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0230","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.gyobfe.2006.09.005","article-title":"Cervical cancer screening and associated treatment costs in France","volume":"34","author":"Bergeron","year":"2006","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0235","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/S0959-8049(01)00292-1","article-title":"The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-up","volume":"37","author":"van Agthoven","year":"2001","journal-title":"Eur J Cancer"},{"issue":"500","key":"10.1016\/j.vaccine.2011.05.018_bib0240","first-page":"e1","article-title":"The economic burden of noncervical human papillomavirus disease in the United States","volume":"198","author":"Hu","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0245","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ygyno.2008.07.032","article-title":"Healthcare resource use and costs associated with cervical, vaginal and vulvar cancers in a large US health plan","volume":"111","author":"Insinga","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0250","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1158\/1940-6207.CAPR-09-0031","article-title":"A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6\/11\/16\/18) vaccine against high-grade cervical and external genital lesions","volume":"2","author":"Kjaer","year":"2009","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.vaccine.2011.05.018_bib0255","doi-asserted-by":"crossref","first-page":"c3493","DOI":"10.1136\/bmj.c3493","article-title":"Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial","volume":"341","author":"Dillner","year":"2010","journal-title":"Br Med J"},{"issue":"5","key":"10.1016\/j.vaccine.2011.05.018_bib0260","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males","volume":"364","author":"Giuliano","year":"2011","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11007286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11007286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T06:51:07Z","timestamp":1560235867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11007286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":52,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0264410X11007286"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.05.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}